Abstract
Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic bone formation in skeletal muscle tissue. In 2007, FOP was authorized as one of the Intractable Disorders by the Ministry of Health, Labour and Welfare of Japan. The Research Committee on FOP is working on the molecular mechanisms underlying heterotopic bone formation and the development of new treatments for FOP.
| Original language | English |
|---|---|
| Pages (from-to) | 1510-1517 |
| Number of pages | 8 |
| Journal | Clinical calcium |
| Volume | 20 |
| Issue number | 10 |
| Publication status | Published - Jan 1 2010 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Medicine(all)
Cite this
[Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva]. / Katagiri, Takenobu; Kamizono, Jyunji; Nakashima, Yasuharu; Kitoh, Hiroshi; Susami, Takafumi; Haga, Nobuhiko.
In: Clinical calcium, Vol. 20, No. 10, 01.01.2010, p. 1510-1517.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].
AU - Katagiri, Takenobu
AU - Kamizono, Jyunji
AU - Nakashima, Yasuharu
AU - Kitoh, Hiroshi
AU - Susami, Takafumi
AU - Haga, Nobuhiko
PY - 2010/1/1
Y1 - 2010/1/1
N2 - Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic bone formation in skeletal muscle tissue. In 2007, FOP was authorized as one of the Intractable Disorders by the Ministry of Health, Labour and Welfare of Japan. The Research Committee on FOP is working on the molecular mechanisms underlying heterotopic bone formation and the development of new treatments for FOP.
AB - Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by progressive heterotopic bone formation in skeletal muscle tissue. In 2007, FOP was authorized as one of the Intractable Disorders by the Ministry of Health, Labour and Welfare of Japan. The Research Committee on FOP is working on the molecular mechanisms underlying heterotopic bone formation and the development of new treatments for FOP.
UR - http://www.scopus.com/inward/record.url?scp=79952197256&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952197256&partnerID=8YFLogxK
M3 - Review article
C2 - 20890033
AN - SCOPUS:79952197256
VL - 20
SP - 1510
EP - 1517
JO - Clinical calcium
JF - Clinical calcium
SN - 0917-5857
IS - 10
ER -